Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction

AIMS: Despite well‐established benefits of sacubitril/valsartan for cardiac reverse remodelling and the prognosis of patients with heart failure with reduced ejection fraction (HFrEF), there are some patients with limited therapeutic response, even with optimal therapy. We assessed the treatment res...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:ESC Heart Fail
Main Authors: Moon, Mi‐Gil, Hwang, In‐Chang, Choi, Wonsuk, Cho, Goo‐Yeong, Yoon, Yeonyee E., Park, Jun‐Bean, Lee, Seung‐Pyo, Kim, Hyung‐Kwan, Kim, Yong‐Jin
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2021
Fag:
Original Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120366/
https://ncbi.nlm.nih.gov/pubmed/33682334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13285
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker